Vivex Biomedical Raises $7.4M for Stem Cell, Implant Technologies

Vivex Biomedical, a biomedical startup focusing on implant technologies and stem cell therapies, raised $7.4 million to use its technology for spinal fusion and other applications, according to an Atlanta Business Chronicle report. The company is developing bone re-growth stimulation technologies and has an adaptive stem cell line called Marrow Isolated Adult Multi-Lineage Inducible cells. Vivex aims to introduce its stem cell and implant technologies to the market by early 2014.

More Articles on Devices:
Alphatec Holdings to Reduce Workforce, Operating Expenses for French Affiliate
Trinity Orthopedics Acquires Expanding Concepts' Patent Portfolio
8 Key Notes on Spine & Orthopedic Medical Device Companies